5+ day, 8+ hour ago   (744+ words) A recent scientific report found almost 19,000 doctored images of antibodies available in the commercial market. A landmark investigation published by Northwestern University’s Reese Richardson found widespread image manipulation in the commercial antibody market. In the online article, more than 15 well-known…...

4+ day, 18+ hour ago   (552+ words) An executive from Thermo Fisher discusses how AI stands to transform the industry without compromising the need for human operators. Use cases for AI tools continue to evolve in biopharmaceutical development and manufacturing. The technology already has tremendous influence on…...

1+ week, 4+ day ago   (1123+ words) The future of biopharmaceutical commercial analytics is not agentic AI versus humans, but governed collaboration between the two. Human-in-the-loop models provide a scalable path forward by combining the speed and breadth of automation with the judgment, accountability, and trust required…...

2+ week, 4+ day ago   (531+ words) An industry expert shares important tips with the Pharma Conversation Podcast about how best to approach a product launch in Europe. Launching a pharmaceutical product in Europe is one of the most strategically significant and operationally complex moves a biotech…...

2+ week, 4+ day ago   (650+ words) An industry expert told us how recent projects in Houston speak to the city’s drive to become a premier biomanufacturing hub. “Each of those buildings, as far as you can see, are all nonprofit medical centers,” said Jason Bock, co-founder…...

2+ week, 6+ day ago   (83+ words) Click below to begin your download. Sponsored by Bora Biologics, Catalent, Enzene, Evotec, KBI Biopharma, Rentschler Biopharma, Rezon Bio, Samsung Biologics, Syngene, Thermo Fisher Scientific, Wheeler Bio Download now to access comprehensive summaries of presentations, panels, and the latest news…...

3+ week, 4+ day ago   (280+ words) The investigational therapy will be used in clinical trials and seeks to treat conditions such as Tay-Sachs and Sandhoff diseases. Under the agreement, Andelyn will use its AAV Curator platform to advance the AAV9-GM2 program. According to the company, the AAV…...

3+ week, 5+ day ago   (251+ words) The initial agreement covers biosimilars of cetuximab, evolocumab, and belimumab with more products in the pipeline. Shanghai Henlius Biotech announced the signing of a strategic collaboration with big biosimilar maker Sandoz to partner on up to 10 biosimilar assets, many of…...